↓ Skip to main content

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?

Overview of attention for article published in Frontiers in Pharmacology, May 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
10 X users

Readers on

mendeley
123 Mendeley
Title
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
Published in
Frontiers in Pharmacology, May 2020
DOI 10.3389/fphar.2020.00791
Pubmed ID
Authors

Mekonnen Sisay

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 123 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 11%
Student > Master 13 11%
Other 11 9%
Student > Bachelor 11 9%
Student > Ph. D. Student 8 7%
Other 26 21%
Unknown 41 33%
Readers by discipline Count As %
Medicine and Dentistry 31 25%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Nursing and Health Professions 9 7%
Biochemistry, Genetics and Molecular Biology 6 5%
Agricultural and Biological Sciences 3 2%
Other 20 16%
Unknown 44 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2023.
All research outputs
#6,543,198
of 24,476,221 outputs
Outputs from Frontiers in Pharmacology
#2,720
of 18,481 outputs
Outputs of similar age
#131,868
of 399,044 outputs
Outputs of similar age from Frontiers in Pharmacology
#97
of 496 outputs
Altmetric has tracked 24,476,221 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 18,481 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,044 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 496 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.